Gilead Sciences Announces Second Quarter 2021 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.71 per share of common stock for the second quarter of 2021. The dividend is payable on June 29, 2021, to stockholders of record at the close of business on June 15, 2021. Future dividends will be subject to Board approval.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005960/en/

Jacquie Ross, Investors
(650) 358-1054

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• AMR Resources Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing September 8, 2026
• Statement: EdgeMode confirms that the current review process with BlackBerry AIF and BLACK AI Group will be extended for up to six months
• Dr. Gary Lawton: Hidden Risks of Combining Liposuction With a Tummy Tuck